688266 泽璟制药
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产189,113-7.89%205,30198,289109,21499,212
在建工程248,998101.67%123,471135,82786,67327,245
无形资产35,478-29.06%50,01169,27091,030116,291
商誉0--0000
其他非流动资产33,865-32.18%49,93363,48589,63997,257
507,45418.37%428,715366,871376,556340,005

流动资产
货币资金2,070,253-3.87%2,153,6792,109,641797,0471,136,632
应收账款178,28924.41%143,304101,14088,98562,371
存货174,370-4.64%182,861110,85298,97851,911
其他流动资产83,011-13.58%96,054198,703306,745155,043
2,505,923-2.72%2,575,8992,520,3361,291,7551,405,956

流动负债
短期借款966,9451.58%951,862795,165390,793131,809
应付票据20,512100.94%10,208000
应付帐款203,3838.82%186,895137,735151,721118,191
其他流动负债164,016-26.94%224,480202,282186,671130,894
1,354,856-1.35%1,373,4461,135,181729,186380,893
流动资产净值1,151,068-4.27%1,202,4531,385,155562,5691,025,063
资产总额减流动负债1,658,5221.68%1,631,1691,752,026939,1261,365,068

非流动负债
长期借款125,700183.42%44,351050,0940
应付债券0--0000
其他非流动负债383,80814.84%334,217107,189101,545111,987
509,50834.59%378,568107,189151,639111,987

总权益
    实收股本264,7080.00%264,708264,708240,000240,000
    储备项目884,306-10.60%989,1501,368,145519,118956,323
股东权益1,149,014-8.36%1,253,8581,632,853759,1181,196,323
非控股权益0-100.00%(1,257)11,98428,36856,759